Story-of-the-week

Vitamin D and the Risk for Type 2 Diabetes in People with Prediabetes
ACP Journals: Annals of Internal Medicine: Published on February 2023In this systematic review and meta-analysis, the authors assessed whether vitamin D administration decreases the risk for diabetes in individuals with prediabetes. TAKE-HOME MESSAGECombining data from three randomized trials, the authors demonstrated that vitamin D reduced the...
DIMS PREMIUM: What are the DIMS Premium Features?
DIMS PremiumThe best Quick Reference app for clinical decision making DIMS Premium delivers up-to-date, comprehensive, and practical information on over 2,000+ drugs, 500+ diseases, and 130+ clinical guidelines.  RemoveKEY FEATURESDESIGNED for Quick and Easy access in the Clinical settingsDIAGNOSE accurately with helpful Clinical Informati...
Association of Intake of Artificial Sweeteners with Risk of Cardiovascular Diseases
BMJ: British Medical Journal: Published on September, 2022The harmful effects of added sugars on various health outcomes including cardiometabolic disorders have been extensively studied, meta-analysed and are currently recognised as major risk factors by public health authorities. In particular, the World Health Organization recommends t...
Efficacy of Montelukast in preventing seasonal recurrence of vernal keratoconjunctivitis in Children
TAKE-HOME MESSAGEVernal keratoconjunctivitis is a chronic, seasonally exacerbated, allergic inflammation of the eye.This prospective study evaluated the efficacy and safety of montelukast in conjunction with typical topical therapies for treating pediatric vernal keratoconjunctivitis (VKC). Patients were evaluated for subjective improvement in...
Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID‐19
Journal of the American Heart Association: published on Jun 2022 COVID‐19 is an infectious illness, with an increased risk of thromboembolism. The overall rate of venous thromboembolism and arterial thromboembolism among patients with COVID‐19 is 21% and 2%, respectively. Therefore, this complication represents an important therapeut...
Long term impact of prophylactic antibiotic use before incision VS after cord clamping on Children by caesarean section
The British Medical Journal (BMJ): Published 17 May 2022 Compared with vaginal delivery, caesarean section carries a substantially increased risk of maternal postpartum infections. This risk can be reduced by routine provision of prophylactic antibiotics. Evidence from randomized controlled trials shows that antibiotics are more effe...
Long-term Paracetamol use could increase the risk of Heart disease and Strokes
Paracetamol has often been cited as a safer alternative to non-steroidal anti-inflammatory drugs (NSAIDs) with regards blood pressure and cardiovascular health. But now researchers have raised concerns about this, suggesting that those taking paracetamol long-term may be at greater risk of heart attack and stroke.Long-term paracetamol use could...
Treatment of Community-Acquired Pneumonia during the COVID-19 Pandemic
The rapidly escalating coronavirus disease 2019 (COVID-19) pandemic has focused attention on the diagnosis and treatment of patients with acute respiratory infection in an unprecedented manner. Although most of the lung injury patients have is believed to be caused by the virus, concern over bacterial co-infection also informs current treatmen...
FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant
COVID-19 Update:In light of the most recent information and data available, today, the FDA revised the authorizations for two monoclonal antibody treatments – bamlanivimab and etesevimab (administered together) and casirivimab and imdevimab – to limit their use to only when the patient is likely to have been infected with or exposed to a varian...
FDA authorizes Covid booster dose of Moderna and Pfizer vaccines for all Adults
The FDA announced it had amended the emergency use authorizations for both the Moderna and Pfizer-BioNTech vaccines allowing for a single booster dose for all individuals 18 years of age and older after completion of primary vaccination with any of the approved COVID-19 vaccines.The CDC also recommends that adults should get a booster at least...
FDA authorizes 1st antiviral oral pill for treatment of COVID 19
The U.S. Food and Drug Administration authorized Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for emergency use for the treatment of mild-to-moderate coronavirus disease in adults and children 12 years and older weighing at least 40 kilograms with positive results of direct SARS-CoV-2 testing, and who...
COVID-19 Update: FDA & CDC Shortens Interval for Booster Dose of Pfizer & Moderna COVID-19 Vaccine
Booster interval and age updatedThe U.S. Food and Drug Administration (FDA) and CDC authorizing the use of a Pfizer-BioNTech & Moderna COVID-19 Vaccine to shorten the time between the completion of a primary series of the 2 vaccines and a booster dose to at least 5 months after completion of the primary vaccination series for individuals 12 yea...